Shionogi is aiming to raise its consolidated net sales to ¥375 billion ($4.1 billion) over the next five years, ahead of a challenging period after 2016 when cholesterol therapy Crestor (rosuvastatin) will be hit by its first patent expiries.
The ...
Hikma Pharmaceuticals is in a position to carry out acquisitions worth up to $400 million in total this year, CEO
Said Darwazah
has told Scrip. "In 2009 we were actively engaged with certain companies and we should see those talks come to fruition ...
China's central government spent Yuan116.2 billion ($17.1 billion) on measures to support reforms to the national pharmaceutical and healthcare system in 2009, and is gearing up for further changes this year, including the full adoption of new ...
Latvia's second-largest pharmaceutical manufacturer Olainfarm is to open a representative office in Bangkok, Thailand, to maintain sales growth in Asia and diversify risks.
Its chairman
Valerijs Maligins
said that the opening of the new office, ...
Dynavax Technologies ' future could be under threat after its cash and cash equivalents fell by $9.7 million to $36.7 million at the end of last year.
The infectious disease-focused biopharmaceutical company's independent accounting firm questioned ...
